Inhibition of tumor growth and metastasis establishment by adenovirus-mediated gene transfer delivery of the antiangiogenic factor 16K hPRL. (Q50925115)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 August 2007

Language	Label	Description	Also known as
English	Inhibition of tumor growth and metastasis establishment by adenovirus-mediated gene transfer delivery of the antiangiogenic factor 16K hPRL.	scientific article published on 28 August 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/17726458

Inhibition of tumor growth and metastasis establishment by adenovirus-mediated gene transfer delivery of the antiangiogenic factor 16K hPRL. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/17726458

1 reference

based on heuristic

inferred from title

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

Jean-Michel Foidart

5

object named as

Jean-Michel Foidart

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

author name string

Ngoc-Quynh-Nhu Nguyen

1

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/17726458

Anne Cornet

2

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/17726458

Silvia Blacher

3

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/17726458

Sébastien P Tabruyn

4

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/17726458

Agnès Noël

6

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/17726458

Joseph A Martial

7

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/17726458

Ingrid Struman

8

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/17726458

publication date

28 August 2007

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/17726458

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/17726458

15

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/17726458

12

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/17726458

2094-2100

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/17726458

Tumor metastasis: mechanistic insights and clinical challenges

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

Critical determinants of metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiogenesis in life, disease and medicine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiogenesis and tumor metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiogenesis as a therapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of urokinase activity by the antiangiogenic factor 16K prolactin: activation of plasminogen activator inhibitor 1 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

The antiangiogenic factor 16K PRL induces programmed cell death in endothelial cells by caspase activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

The antiangiogenic factor, 16-kDa human prolactin, induces endothelial cell cycle arrest by acting at both the G0-G1 and the G2-M phases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular targeting of antiangiogenic factor 16K hPRL inhibits oxygen-induced retinopathy in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

Endogenous angiogenesis inhibitors and their therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of tumor angiogenesis by cannabinoids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-tumor efficacy of human angiostatin using liver-mediated adeno-associated virus gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in a murine pulmonary metastasis model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo bioluminescence tumor imaging of RGD peptide-modified adenoviral vector encoding firefly luciferase reporter gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

Methods for delivery of adenoviral vectors to tumor vasculature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300294

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.MT.6300294

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/17726458

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/17726458

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50925115&oldid=1466171080"